Mosunetuzumab-axgb may be better tolerated by older adults with relapsed or refractory follicular lymphoma and patients with poor performance status.
Mallory Norman, PharmD, BCOP
Advertisement
Articles by Mallory Norman, PharmD, BCOP
Importantly, when considering the useof small molecule inhibitors, potential drug interactions must be evaluated.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter
2
Lilly Prepares for Retatrutide FDA Filing Following Additional Phase 3 Data in Diabetes, CVD
3
Combating the Decline in Influenza Vaccination Rates: A Pharmacist’s Perspective
4
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure
5